Laurion Capital Management LP Hutchmed (China) LTD Call Options Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HCM
# of Institutions
66Shares Held
6.61MCall Options Held
8.2KPut Options Held
9.2K-
Schroder Investment Management Group London, X02.84MShares$43 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1MShares$15.2 Million0.02% of portfolio
-
State Street Corp Boston, MA348KShares$5.26 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.77 Million0.13% of portfolio
-
M&G PLC London, X0259KShares$3.91 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.62B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...